Key terms

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest AVXL news

Mar 28 8:46am ET Largest borrow rate increases among liquid names Mar 20 8:46am ET Largest borrow rate increases among liquid names Mar 18 7:35am ET Anavex initiates placebo-controlled U.S. Phase 2 trial of ANAVEX3-71 Feb 27 12:35pm ET SHAREHOLDER ALERT: Potential Recovery for Anavex Life Sciences Corp. (AVXL) Investors Feb 15 6:30am ET Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL), PolyPid (PYPD) and Nyxoah (NYXH) Feb 09 8:45am ET Largest borrow rate increases among liquid names Feb 07 11:55am ET Buy Rating Affirmed for Anavex Life Sciences Amid Positive Alzheimer’s Program Outlook and Financial Stability Feb 07 7:33am ET Anavex reports Q1 EPS (11c) vs. (17c) last year. Jan 25 8:45am ET Largest borrow rate increases among liquid names Jan 24 7:37am ET Anavex reports publication of ANAVEX 3-71 human study in clinical journal Jan 23 8:45am ET Largest borrow rate increases among liquid names Jan 22 2:45pm ET Anavex call volume above normal and directionally bullish Jan 22 12:50pm ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Definitive Healthcare Corp (DH), Anavex Life Sciences (AVXL) and Inari Medical (NARI) Jan 08 7:53am ET Anavex announces grant of U.S. patent covering blarcamesine Jan 05 11:01am ET Biotech Alert: Searches spiking for these stocks today Jan 04 11:13am ET Biotech Alert: Searches spiking for these stocks today Jan 03 8:35am ET Maintaining Buy on Anavex: A Balanced View Amid Clinical Trial Setbacks and Future Potential Jan 03 8:31am ET Anavex price target lowered to $40 from $54 at H.C. Wainwright Jan 02 9:27am ET Maintaining Buy on Anavex: Setback in Rett Syndrome Trial Offset by Alzheimer’s Focus and Upcoming European Filing Jan 02 8:12am ET Anavex provides update on Rett Syndrome Program
Today 12:45pm ET Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class Action - AVXL Yesterday 5:42pm ET SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Yesterday 11:45am ET Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL Yesterday 11:30am ET INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm Yesterday 7:30am ET Investors in Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL Yesterday 7:30am ET AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline Yesterday 7:00am ET INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm Apr 14 1:02pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXL Apr 14 7:15am ET DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Apr 13 10:45pm ET Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact Levi & Korsinsky Apr 13 10:00pm ET SHAREHOLDER DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm Apr 13 6:45pm ET Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact Levi & Korsinsky Apr 12 12:02pm ET SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm Apr 12 11:45am ET Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL Apr 11 5:42pm ET INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Apr 11 12:45pm ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Corporation Lawsuit - AVXL Apr 11 12:27pm ET SHAREHOLDER ALERT: Anavex Life Sciences Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information Apr 11 12:01pm ET SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm Apr 11 7:30am ET Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL Apr 11 7:00am ET IMPORTANT DEADLINE ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm Apr 11 5:30am ET Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More Apr 11 4:30am ET Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders Apr 10 5:31pm ET SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Apr 09 5:21pm ET ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Apr 09 1:00pm ET Shareholders of Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL Apr 09 6:30am ET Shareholders of Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL Apr 09 6:00am ET DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm Apr 09 5:30am ET Shareholders of Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL Apr 08 9:30pm ET AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline Apr 08 2:30pm ET Anavex Life Sciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AVXL Apr 08 1:45pm ET Investors in Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL

AVXL Financials

1-year income & revenue

Key terms

AVXL Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

AVXL Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms